Sunshine Biopharma SBFM
NASDAQ SBFM
$0.79 -0.03 (-3.41%)
As of: Sep 29, 2026 · 3:58 PM EDT

Sunshine Biopharma (SBFM) Finished Goods (2019 - 2020)

Updated

Sunshine Biopharma's Finished Goods was $23,771 in Q4 2020, up 49.4% from $15,910 a year earlier.

Analysis

Sunshine Biopharma (SBFM) Finished Goods (2019 - 2020) Analysis & Trends

  • In earlier years, Finished Goods was $15,910 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Sunshine Biopharma 1.12 Mn -37.97 Mn 2.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 23,771.00
Dec 31, 2019 15,910.00
API Access

Sunshine Biopharma Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=SBFM&period=max&api_key=YOUR_API_KEY